MIMS CDS footer logo
  • Home
  • Solutions
    • MIMS Integrated
    • eMIMSplus
  • Practices
    • Hospitals
    • Pharmacies
    • Clinics
    • Telemedicine
    • Become A Partner
  • Learn More
    • Editorial Process
    • Testimonials
    • FAQs
    • Contact Support
  • Blog
  • CONTACT US

Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes

by MIMS CDS Asia | Sep 22, 2025 | Ian Lim

6 minutes read time Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterised by chronic hyperglycaemia resulting from a combination of insulin resistance and impaired insulin secretion. Management of T2DM commonly involves lifestyle...

Recent Posts

  • Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes
  • Implementing Clinical Decision Support System (CDSS): A Path to Success
  • Paracetamol Use in NSAID-Allergic Patients – Are You Overlooking the Cross-Sensitivity Risk?
  • Preventing Serotonin Syndrome with Clinical Decision Solutions: A Safety Imperative in Psychiatry
  • The Impact of Diuretics on QT Prolongation
MIMS CDS footer logo

Safer Medications, Better Care.

  • Follow
  • Follow
Navigate
Solutions
– MIMS Integrated
– eMIMSplus
Hospitals
Pharmacies
Clinics
Blog
Editorial Process
Testimonials
FAQs
Become a Partner
Contact Us
Get In Touch


Sales

cdssales@mims.com



Support

cdssupport@mims.com



Regional Headquarters

438B Alexandra Rd, Alexandra Technopark, #06-11 Singapore 119968
Copyright © 2025 MIMS CDS Asia | Privacy Policy